Related Experiment Video
Updated: May 21, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Identification of high-risk chronic heart failure patients in clinical practice: role of changes in left ventricular
Mariantonietta Cicoira1, Andrea Rossi, Andrea Chiampan
1Department of Medicine, Section of Cardiology, University of Verona, Verona, Italy. mariantonietta.cicoira@univr.it
Insights
In stable chronic heart failure (CHF), left ventricular (LV) function improves in 24% of patients. Worsening LV systolic function significantly increases mortality risk, regardless of other severity markers.
Area of Science:
- Cardiology
- Heart Failure Research
- Echocardiography
Background:
- Left ventricular (LV) dysfunction and remodeling are central to chronic heart failure (CHF) progression.
- Understanding LV changes is crucial for managing CHF patients.
Purpose of the Study:
- To track LV dysfunction and function changes in stable CHF patients on optimal therapy.
- To identify predictors of LV changes and their prognostic impact on mortality.
Main Methods:
- 318 CHF outpatients underwent serial echocardiography (baseline and 1 year).
- Patients were followed for at least 12 months, with all-cause mortality as the primary endpoint.
- Cox analysis assessed the prognostic impact of LV function changes.
Main Results:
- Mean LV ejection fraction (LVEF) improved slightly from 33% to 36%.
- 24% of patients showed LVEF improvement (>5 points), 58% remained stable, and 17% worsened (>5 points).
- Worsening LV function (group 3) was linked to a 4-fold higher mortality risk compared to improved function (group 1).
Conclusions:
- LV function improves in a subset (24%) of stable CHF outpatients.
- A decline in LV systolic function independently predicts increased mortality risk in CHF.
- Serial echocardiography is vital for assessing prognosis in CHF management.
Background:
Left ventricular (LV) dysfunction and remodeling are key pathophysiological features underlying disease progression in chronic heart failure (CHF).
Hypothesis:
To describe the course of LV dysfunction and identify predictors and prognostic impact of changes in LV volumes and function in stable CHF patients under optimal therapy.
Methods:
There were 318 consecutive CHF outpatients who underwent a repeated echocardiographic evaluation at baseline and at 1 year and subsequently followed-up for at least 12 months. The end point of the study was all-cause mortality.
Results:
Mean LV ejection fraction (LVEF) was 33 ± 7% at baseline and 36 ± 9% at follow-up. Twenty-four percent of patients had an improvement of LVEF >5 absolute points (group 1); 58% remained stable (group 2), 17% worsened at >5 absolute points (group 3). Age, New York Heart Association class, diuretic dose, renal function, and baseline LVEF were independent predictors of LVEF improvement at 1 year. At the Cox analysis, patients in group 3 had a 4-fold higher risk of death when compared with group 1 (hazard ratio: 3.99, 95% confidence interval: 1.6-9.9, P = 0.002), independently of age, etiology, and symptoms severity.
Conclusions:
In stable CHF outpatients, LV function improves in 24% of cases; a modest decrease in LV systolic function is associated with a significantly higher risk of all-cause mortality, independent of other markers of disease severity.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure VII: Nursing Interventions
Heart Failure I: Introduction
Heart Failure III: Clinical Manifestations